These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
270 related items for PubMed ID: 18799339
21. Structured interruptions of highly active antiretroviral therapy in cycles of 4 weeks off/12 weeks on therapy in children having a chronically undetectable viral load cause progressively smaller viral rebounds. Palacios GC, Sanchez LM, Briones E, Ramirez TJ, Castillo H, Rivera LG, Vazquez CA, Rodriguez-Padilla C, Holodniy M. Int J Infect Dis; 2010 Jan; 14(1):e34-40. PubMed ID: 19467895 [Abstract] [Full Text] [Related]
22. Disseminated bacille Calmette-Guérin in Iranian children with severe combined immunodeficiency. Sadeghi-Shabestari M, Rezaei N. Int J Infect Dis; 2009 Nov; 13(6):e420-3. PubMed ID: 19403320 [Abstract] [Full Text] [Related]
23. Long-term response to highly active antiretroviral therapy with lopinavir/ritonavir in pre-treated vertically HIV-infected children. Larrú B, Resino S, Bellón JM, de José MI, Fortuny C, Navarro ML, Gurbindo MD, Ramos JT, Soler Palacín P, Léon JA, Asensi M, Mellado MJ, Muñoz-Fernández MA. J Antimicrob Chemother; 2008 Jan; 61(1):183-90. PubMed ID: 18025025 [Abstract] [Full Text] [Related]
24. [Immune reconstitution syndrome due to BCG in HIV-treated children]. Miranda-Choque E, Candela-Herrera J, R Segura E, Farfán-Ramos S, Barriga A. Rev Peru Med Exp Salud Publica; 2012 Jan; 29(4):498-502. PubMed ID: 23338635 [Abstract] [Full Text] [Related]
25. Idiopathic disseminated bacillus Calmette-Guérin infection: a French national retrospective study. Casanova JL, Blanche S, Emile JF, Jouanguy E, Lamhamedi S, Altare F, Stéphan JL, Bernaudin F, Bordigoni P, Turck D, Lachaux A, Albertini M, Bourrillon A, Dommergues JP, Pocidalo MA, Le Deist F, Gaillard JL, Griscelli C, Fischer A. Pediatrics; 1996 Oct; 98(4 Pt 1):774-8. PubMed ID: 8885960 [Abstract] [Full Text] [Related]
26. Tuberculosis during early antiretroviral-induced immune reconstitution in HIV-infected children. Zampoli M, Kilborn T, Eley B. Int J Tuberc Lung Dis; 2007 Apr; 11(4):417-23. PubMed ID: 17394688 [Abstract] [Full Text] [Related]
28. Effectiveness and tolerability of a once-daily amprenavir/ritonavir-containing highly active antiretroviral therapy regimen in antiretroviral-naïve patients at risk for nonadherence: 48-week results after 24 weeks of directly observed therapy. Jayaweera DT, Kolber MA, Brill M, Tanner T, Campo R, Rodriguez A, Chu HM, Garg V. HIV Med; 2004 Sep; 5(5):364-70. PubMed ID: 15369512 [Abstract] [Full Text] [Related]
29. Incidence, spectrum and outcome of immune reconstitution syndrome in HIV-infected children after initiation of antiretroviral therapy. Gkentzi D, Tebruegge M, Tudor-Williams G, Walters S, Lyall H, Sharland M, Doerholt K. Pediatr Infect Dis J; 2014 Sep; 33(9):953-8. PubMed ID: 24618936 [Abstract] [Full Text] [Related]
30. Two-year outcomes of children on non-nucleoside reverse transcriptase inhibitor and protease inhibitor regimens in a South African pediatric antiretroviral program. Jaspan HB, Berrisford AE, Boulle AM. Pediatr Infect Dis J; 2008 Nov; 27(11):993-8. PubMed ID: 18818556 [Abstract] [Full Text] [Related]
34. Morbidity in HIV-1-Infected children treated or not treated with highly active antiretroviral therapy (HAART), Abidjan, Cote d'Ivoire, 2000-04. Walenda C, Kouakoussui A, Rouet F, Wemin L, Anaky MF, Msellati P. J Trop Pediatr; 2009 Jun; 55(3):170-6. PubMed ID: 19066169 [Abstract] [Full Text] [Related]
35. Severe axillary lymphadenitis after BCG vaccination: alert for primary immunodeficiencies. Santos A, Dias A, Cordeiro A, Cordinhã C, Lemos S, Rocha G, Faria E. J Microbiol Immunol Infect; 2010 Dec; 43(6):530-7. PubMed ID: 21195982 [Abstract] [Full Text] [Related]
36. The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy. Cardiello P, Srasuebkul P, Hassink E, Mahanontharit A, Samor T, Ruxrungtham K, Lange J, Cooper D, Phanuphak P. HIV Med; 2005 Mar; 6(2):122-8. PubMed ID: 15807718 [Abstract] [Full Text] [Related]
37. Immunity status in children with Bacille Calmette-Guerin adenitis. A prospective study in Tehran, Iran. Samileh N, Ahmad S, Farzaneh A, Shahnaz R, Lida F, Mohammad N. Saudi Med J; 2006 Nov; 27(11):1719-24. PubMed ID: 17106549 [Abstract] [Full Text] [Related]
38. Varicella zoster as a manifestation of immune restoration disease in HIV-infected children. Tangsinmankong N, Kamchaisatian W, Lujan-Zilbermann J, Brown CL, Sleasman JW, Emmanuel PJ. J Allergy Clin Immunol; 2004 Apr; 113(4):742-6. PubMed ID: 15100682 [Abstract] [Full Text] [Related]
39. Safety of intradermal Bacillus Calmette-Guerin vaccine for neonates in Eastern Saudi Arabia. Al-Salem AH, Kothari MR, AlHani HM, Oquaish MM, Khogeer SS, Desouky MS. Saudi Med J; 2012 Feb; 33(2):172-6. PubMed ID: 22327758 [Abstract] [Full Text] [Related]
40. [Modern microbiological methods in diagnosis of adverse reactions after BCG vaccination. Case reports]. Zwolska Z, Augustynowicz-Kopeć E, Zabost A, Ziółkowski J, Buchwald J, Płończak M, Walas W, Ziebiński M. Pneumonol Alergol Pol; 2004 Feb; 72(11-12):505-11. PubMed ID: 16329351 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]